A/Prof. Thomas Eade

A/Prof. Thomas Eade
Thomas
Eade
MBBS, FRANZCR, Radiation Oncologist

Languages spoken

English

Overview

Centres

Mater Hospital, Sydney (Oncology)
Mater Hospital, Sydney (Oncology)

The Mater Hospital, 25 Rocklands road, North Sydney, NSW

-33.83166139694626, 151.20156682718073
/au/our-centres/mater-hospital-sydney-oncology
Macquarie University Hospital (Oncology)
Macquarie University Hospital (Oncology)

Hospital Building, Suite 1, Level B2, 3 Technology Place, Macquarie University, NSW, 2109

-33.77308982351843, 151.11793004035897
/au/our-centres/macquarie-university-hospital
North Shore
North Shore

North Shore Health Hub, Tower A, Level 1, 7 Westbourne Street, St Leonards NSW 2065, Australia

-33.82024297423824, 151.19062046149045
/au/our-centres/north-shore

Specialises in

Prostate cancer
Condition
Condition/Cancer
Condition/Cancer/Prostate Cancer

Treatments

Brachytherapy
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Brachytherapy
Intensity-modulated radiation therapy (IMRT)
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Intensity modulated radiation therapy (IMRT)
Stereotactic ablative/body radiation therapy (SABR/SBRT)
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Stereotactic body radiation therapy (SBRT)

Special clinical interest in prostate cancer.

Professor Thomas Eade returned to Australia in January 2007, after time spent working as the Thomas Baker Fellow at the Fox Chase Cancer Center in Philadelphia, USA. Fox Chase, which specialises in the treatment of prostate cancer, is one of the leading Radiation Oncology Centres in the USA. While in America, A/Professor Eade trained in the latest radiation therapy techniques, including IMRT, intraoperative real-time seed brachytherapy and high dose rate brachytherapy.

A/Professor Eade is now recognised across the country for his expertise in the IMRT/VMAT and IGRT techniques for the treatment of prostate cancer. A/Professor Eade has pioneered some of the most advanced prostate cancer 'external beam' treatments in Australia. In 2008, A/Professor Eade also established a permanent seed brachytherapy programme and high dose rate brachytherapy programme. A/Professor Eade is also one of a few specialists in Australia able to offer intraoperative real time seed brachytherapy treatment for prostate cancer. A/Professor Eade has been a guest speaker at state, national and international meetings on advanced radiation techniques.

In addition to his strong patient care and outcome focus, A/Professor Eade is also a committed researcher. A/Professor Eade is the Director of Research in the Northern Sydney Cancer Centre and also developed the prospective database for prostate cancer radiotherapy, which is in use across the North Shore and Central Coast campus. A key area of interest for A/Professor Eade is in researching and evaluating the delivery of new technology in radiotherapy. He is the Principle Investigator for the first Australian study of Stereotactic Radiotherapy (five treatments) for prostate cancer, which is currently recruiting (HEAT study).

A/Professor Eade has authored articles on dose escalation and IMRT for prostate cancer publications in major international oncology journals.